Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Evelo Biosciences

Evelo Biosciences

Evelo Biosciences is a Cambridge, Massachusetts-based company.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

July 13, 2017
Evelo Biosciences raises a $50,000,000 series B round from Flagship Pioneering.
July 2017
Evelo Biosciences raises a $50,000,000 series B round from Celgene, Flagship Pioneering and Mayo Clinic.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
July 8, 2021
BioSpace
PlateletBio Names Derek Adams, Ph.D., as Chief Operating Officer - read this article along with other careers information, tips and advice on BioSpace
BioSpace
June 1, 2021
BioSpace
Evelo Biosciences, Inc., a clinical stage biotechnology company developing a new modality of orally delivered medicines, announced the appointment of Mark Plinio as Chief Commercial Officer, effective June 14, 2021.
BioSpace
April 20, 2021
BioSpace
-Evelo presents late-breaking abstract at the International Society of Atopic Dermatitis Annual Meeting- -Meaningful improvements over placebo on clinical scores, including new data released on key IGA endpoints- -Initiation of Phase 2 trial of EDP1815 in atopic dermatitis expected in 3Q 2021-
Alex Keown
April 16, 2021
BioSpace
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
SHOW MORE

References

Golden logo
By using this site, you agree to our Terms & Conditions.